Arkolith/Insider Trading/MLYS/Form 4

Rodman David Malcom

Chief Medical OfficerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Apr 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$549K
Net Open-Market Flow
-$549K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Sell(S)6K$27.66$176K70K
Apr 13, 2026Option exercise(M)4K$10.20$36K86K
Apr 13, 2026Option exercise(M)4K$14.25$59K90K
Apr 13, 2026Sell(S)14K$26.54$373K76K
Apr 13, 2026Option exercise(M)6K$1.08$7K82K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 13, 2026Option exercise(M)6K—$019K
Apr 13, 2026Option exercise(M)4K—$0120K
Apr 13, 2026Option exercise(M)4K—$092K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001933414-26-000076) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML